Trial Profile
Open Label Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs V3-X (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms cholangio
- Sponsors Immunitor
- 29 Aug 2019 Planned End Date changed from 20 Apr 2019 to 20 Apr 2020.
- 29 Aug 2019 Planned primary completion date changed from 20 Feb 2019 to 20 Feb 2020.
- 08 Feb 2017 New trial record